Considering the new era of CHC therapy via Direct-Acting antivirals(DAAs), DAAs are associated with > 95% cure rate and reduction in risk of developing HCC and are significantly beneficial in reducing diabetes mellitus, the levels of liver enzymes (GOT, GPT, and GGT) [33, 35], and the severity of fatty liver disease[36]. Here, GPT is linked to fatty liver disease.